Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus. - Wikidata - awgldk - TriplyDB

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

http://www.wikidata.org/entity/Q36759944

about

Alphavirus-based vaccines Ebola virus vaccines: an overview of current approaches Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA What is Ebola?Ebola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus [Overview of the Ebola vaccines in pre-clinical and clinical development].Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice Development and Characterization of a Guinea Pig-Adapted Sudan Virus.Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).Self-replicating alphavirus RNA vaccines.RNA-based viral vectors.The alien replicon: Artificial genetic constructs to direct the synthesis of transmissible self-replicating RNAs: In vivo synthesised heterologous (alien) RNA constructs are capable of initiating self-replication following transmission to the host o Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.Ebola vaccines in clinical trial: The promising candidates.An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.Ebola virus vaccines - reality or fiction?Therapeutics for postexposure treatment of Ebola virus infection.A nonhuman primate scrub typhus model: protective immune responses induced by pKarp47 DNA vaccination in cynomolgus macaques.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Designing Efficacious Vesicular Stomatitis Virus-Vectored Vaccines Against Ebola Virus.Vaccines against 'the other' Ebolavirus species.Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak.Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.From bench to almost bedside: the long road to a licensed Ebola virus vaccine.Alphavirus-Based Vaccines.Alphavirus-Based Vaccines.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus Animal Models of Ebolavirus Infection Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge

P2860

Q26994724-4BB217B4-8F9C-40C3-A007-62C462D6DA02 Q26999232-96D84FA5-AFDB-42B2-B882-974672BDC39A Q28396399-C2A5D887-D00E-4A89-BE9C-8974CB871C0B Q30205723-216EF88E-5DA3-423D-97FB-13D6F05347DA Q30234637-52882EF0-2E72-4672-B4A6-37BE34830827 Q30235073-466CA271-30D5-4DBC-A956-5D732111DB84 Q30245207-3BB17DA0-D948-4890-A8C4-87CCEEE6B8E9 Q30724121-376890D5-BA06-4AE0-AD3F-12EAF8F1C11B Q34261536-63D20D7D-A8D2-44EF-B080-96A845CB523B Q35202880-EA7DB07D-6633-43EF-BB73-7301A93C5FB3 Q35793699-34D9E4B7-7A3C-45DC-8CB5-1EFC44DDAD53 Q36040533-D4BD674B-2425-488E-9BA1-4FD697366C48 Q36043170-962DD580-5C6C-4F0A-8187-71E8EFFA76D3 Q36043238-F5520F31-91BD-4F67-8EDC-679FB14E015C Q36433906-BBC4444F-9279-40E4-9FA6-D24E3392B50D Q36845999-ABCE3B68-B98D-4426-9B8F-95E8E78AA90A Q38255634-E6171342-AE3E-4BB3-89D3-DA0E27E4F6E2 Q38266413-5940CEE4-3828-48C2-BF78-78EA0BBD68CA Q38266429-8C009296-24A1-41D5-A638-B1FF825DF7A2 Q38269845-10D9A672-4768-4E53-A1B9-485C86686027 Q38808678-6FE7EBB2-CBB7-4CCA-8613-8CAA6C87C082 Q38834286-75FEF345-B88E-4670-A49A-DA814B31DACE Q38878840-6FDC0B38-3649-412B-965F-873F70F7B045 Q38881265-68D0344B-CFDE-4640-9A96-A7E69D590283 Q38980947-4E9FD403-8B93-4C63-A23A-C0622AECF476 Q39338426-42AE71E9-96D7-49C5-B33A-7626B015837C Q40052567-D8CEC21A-AC6A-49D9-A972-207D42DD83D4 Q40109987-E3618619-4B9E-43C2-B098-FFB7594BC711 Q40112699-B9F37075-2B8D-45F4-979B-66D678D3F757 Q41936026-8C5C800C-03AC-4D82-BF0E-24206E6C4109 Q42753196-4E62A822-4B90-4C08-BD39-A63A733172C0 Q44106264-A775E8C2-9C1E-4FCE-B924-354C258ADBFA Q50870504-CB037B65-CD36-4D01-838E-56CAAFE690C9 Q51072912-9BCB292F-16EB-4909-A7A7-70DBE072A87B Q56535662-0BE0E281-EB26-4FD4-9F12-EC313E9DD2A2 Q56541916-33E18859-0F39-415B-9505-513387DF2386 Q56945995-2520D9F2-ADC1-4D7D-9FF7-5AA29E235868

P2860

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

http://www.wikidata.org/entity/Q36759944

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Venezuelan equine encephalitis ...... sol challenge with ebolavirus.

@ast

Venezuelan equine encephalitis ...... sol challenge with ebolavirus.

@en

type

label

Venezuelan equine encephalitis ...... sol challenge with ebolavirus.

@ast

Venezuelan equine encephalitis ...... sol challenge with ebolavirus.

@en

prefLabel

Venezuelan equine encephalitis ...... sol challenge with ebolavirus.

@ast

Venezuelan equine encephalitis ...... sol challenge with ebolavirus.

@en

P1433

Q36759944-66A3F422-4CE2-4F8B-A356-B28BFCEEFD9B

P1476

Q36759944-11AB8AC2-D1A6-47C4-ACAC-DE8929BA4D84

P2093

Q36759944-12D3F68D-6E2B-4108-B2A4-F7B354D5349C

Q36759944-19E0EF48-BBF3-4344-AEF9-F61178548276

Q36759944-316ED1AA-67E3-4D44-932B-E7A0A82D1FBB

Q36759944-5503F4A4-E963-4DD3-B905-23D7FB3AA66A

Q36759944-6DBA9361-ED24-4A09-BCA7-07313FBDC8A0

Q36759944-7666BA24-19B4-4DB1-8923-B7D8924E6B37

Q36759944-7D1CE30C-03BE-4A48-A607-1C2D664D0021

Q36759944-8F7297EF-440F-4CC3-9632-033AAC5E9DE6

Q36759944-9EFB786F-E2BC-4B51-95B9-378DD97B1089

Q36759944-A518F2D2-3FC5-406C-8174-FD7DA981A6DA

P2860

Q36759944-04E3416B-BAC7-4863-9E68-C72F9FE7DE89

Q36759944-07384504-1DFD-49CD-B94C-4C5D4E660FC1

Q36759944-08189048-A269-45D8-BAD8-4678F09B167A

Q36759944-0BBBE05E-D769-4EF1-B9B4-2D9F1E39E368

Q36759944-0E272B4E-9770-4DC5-8826-BB0A7B5E3DAF

Q36759944-119D7FB3-14ED-4BC7-9B75-4CF4D014B214

Q36759944-1446D8AB-763B-4385-B88D-EC76C1A98DB4

Q36759944-1AD51A19-992E-44C1-86C3-EE13FE338487

Q36759944-23625F51-4602-4F6D-A790-16375A977494

Q36759944-2B7380DD-833A-409F-8DB7-CD767857F96B

P304

Q36759944-990401C2-06B2-419F-BE05-506C23BFB097

P31

Q36759944-84874E98-04F1-4786-97EB-7CBA1F7E00EC

P356

Q36759944-107BED4D-2D62-4727-A3C2-F4ABBECA58D5

P407

Q36759944-91928CE6-3A4A-453C-AED9-9B446D345FAF

P433

Q36759944-2BAB052B-351D-45FA-B9A0-7F03C8B5F4F2

P478

Q36759944-1BCBE4E2-EB52-49AC-A74E-30843BA64434

P50

Q36759944-4ADA5FB5-3878-40C3-BAB3-8088FC43E9B2

Q36759944-6F364A4A-20FA-43CF-8202-C6D04BF2D6C2

Q36759944-A75C019F-1F1A-4DD6-994F-38760CEDAAE5

Q36759944-CAF651E2-C03D-419C-B8DC-CAC2C5EA4BED

P577

Q36759944-30D35E15-10C1-486B-9AE4-47648180C770

P698

Q36759944-74CF57F6-8486-44A6-9526-86435B69FC7E

P932

Q36759944-5D001FCA-08AF-46DB-902E-D5F398AE13EB

P356

P1433

Journal of Virology

P1476

Venezuelan equine encephalitis ...... osol challenge with ebolavirus

@en

P2093

Ana I Kuehne

http://www.w3.org/2001/XMLSchema#string

Andrew S Herbert

http://www.w3.org/2001/XMLSchema#string

Donald K Nichols

http://www.w3.org/2001/XMLSchema#string

James F Barth

http://www.w3.org/2001/XMLSchema#string

Jonathan F Smith

http://www.w3.org/2001/XMLSchema#string

Kurt I Kamrud

http://www.w3.org/2001/XMLSchema#string

Laura I Prugar

http://www.w3.org/2001/XMLSchema#string

Majidat A Muhammad

http://www.w3.org/2001/XMLSchema#string

Mary Kate Hart

http://www.w3.org/2001/XMLSchema#string

Max Custer

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of genetically diverse Marburg viruses from Egyptian fruit bats

Experimental inoculation of plants and animals with Ebola virus

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

Fruit bats as reservoirs of Ebola virus

Alphavirus vectors: development and potential therapeutic applications.

Potential for Ebola transmission between gorilla and chimpanzee social groups.

Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats.

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species

P304

4952-4964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.03361-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer L. Groebner

P577

2013-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23408633

http://www.w3.org/2001/XMLSchema#string

P932

3624300

http://www.w3.org/2001/XMLSchema#string